Michael Scolaro

Michael Scolaro

Nov 10, 2017

Group 6 Copy 197
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Does fracking contaminate water with hormone disrupting chemicals?

One of the greatest joys for those who want to start a family is to be pregnant and have a healthy baby...

Can Data Management Tools Improve Research Efficiency and Reproducibility?

Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

Do healthy arteries equal a healthy brain?

Our group has been intensely studying how vascular and cognitive health intersect. The clustering of cardiovascular...

Backer Badge Funded